KitoZyme and Janssen PMP, a division of Janssen Pharmaceutica NV, sign an exclusive partnership

• Exclusive collaboration agreement with Janssen PMP, a division of Janssen Pharmaceutica NV, to evaluate and develop KitoZyme's chitosan proprietary technology for post-harvest use on fresh produce. 

• Janssen PMP will fund and drive all testing and development work.

KitoZyme, the pioneer and global leader of high-quality fungal chitosan and Janssen PMP, a division of Janssen Pharmaceutica NV, have signed an Exclusive Collaboration Agreement to evaluate and develop KitoZyme technologies for post-harvest use on fresh produce. 

The agreement aims to evaluate and develop KitoZyme's cutting-edge technologies for post-harvest use on fresh produce, leveraging Janssen PMP's expertise and resources in this field. The collaboration is set to pave the way for innovative solutions to address food waste globally. KitoZyme has granted Janssen PMP the exclusive right to evaluate KitoZyme chitosan technologies for post-harvest storage preservation of fruits and vegetables globally. 

″Being able to control post-harvest pathogens and to extend fruits and vegetables shelf life with an effective natural compound such as KitoZyme’s chitosan is key in our development. This technology is the only chitosan produced from fungi already approved in Europe and USA for post-harvest use. Moreover, this technology is approved for Organic farming in some EU countries and is Vegan compliant″, said Geoffroy de Chabot-Tramecourt, Director R&D and Business Development at Janssen PMP. 

″We are very excited to announce this partnership with Janssen PMP, a division of Janssen Pharmaceutica and a leader in its field. It fits very well with our vision to associate on a mutually exclusive basis our unique fungal sourced biopolymer into high value added applications.″, reacted François Blondel, CEO and Managing Director of KitoZyme.

About JANSSEN PMP

Janssen PMP (www.janssenpmp.com) is a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. 

Janssen PMP is a long-established world leader in the development and formulation of new and highly effective active substances and end-use products for the protection of materials and food, especially fruits and vegetables. With more than 50 years' experience in post-harvest treatments and Plant Protection, Janssen PMP has developed strong technical and commercial expertise. Through protection of our surroundings, we aim to protect the health and well-being of the people in the environment in which our products are being used. 

About KitoZyme

KitoZyme S.A. (www.kitozyme.com and www.kitogreen-agri.com), founded in December 2000, is a pioneer and global leader of fungal chitosan manufacturing. Located in Herstal - Liège, Belgium, the company was established in order to capitalize on the great potential found in the field of fungal biopolymer extraction and offer safer and healthier alternative ingredients to remove or reduce petrochemicals, animal-derived, or toxic ingredients, in several sectors, namely agriculture, winemaking, and health and cosmetics.